Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wiseman, 2008, The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: A global perspective, Proc Nutr Soc., 67, 253, 10.1017/S002966510800712X
Ioannidis, 2013, Implausible results in human nutrition research, BMJ., 347, f6698, 10.1136/bmj.f6698
Davey Smith, 2003, ‘Mendelian randomization’: Can genetic epidemiology contribute to understanding environmental determinants of disease?, Int J Epidemiol., 32, 1, 10.1093/ije/dyg070
Pierce, 2013, Efficient design for Mendelian randomization studies: Subsample and 2-sample instrumental variable estimators, Am J Epidemiol., 178, 1177, 10.1093/aje/kwt084
Burgess, 2015, Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors, Eur J Epidemiol., 30, 543, 10.1007/s10654-015-0011-z
Lippman, 2009, Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT), JAMA., 301, 39, 10.1001/jama.2008.864
Klein, 2011, Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT), JAMA., 306, 1549, 10.1001/jama.2011.1437
Schumacher, Prostate cancer metaanalysis of more than 140,000 men identifies 63 novel prostate cancer susceptibility loci, Nat Genet.
Amos, 2017, The OncoArray Consortium: A network for understanding the genetic architecture of common cancers, Cancer Epidemiol Biomarkers Prev., 26, 126, 10.1158/1055-9965.EPI-16-0106
Morris, 2012, Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes, Nat Genet., 44, 981, 10.1038/ng.2383
InterAct Consortium, 2011, Design and cohort description of the InterAct Project: An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study, Diabetologia., 54, 2272, 10.1007/s00125-011-2182-9
Lotta, 2016, Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: A Mendelian randomisation analysis, PLoS Med., 13, e1002179, 10.1371/journal.pmed.1002179
Cornelis, 2015, Genome-wide association study of selenium concentrations, Hum Mol Genet., 24, 1469, 10.1093/hmg/ddu546
Evans, 2013, Genome-wide association study identifies loci affecting blood copper, selenium and zinc, Hum Mol Genet., 22, 3998, 10.1093/hmg/ddt239
Mao, 2016, Genetic polymorphisms that affect selenium status and response to selenium supplementation in United Kingdom pregnant women, Am J Clin Nutr., 103, 100, 10.3945/ajcn.115.114231
Welter, 2014, The NHGRI GWAS Catalog, a curated resource of SNP-trait associations, Nucleic Acids Res., 42, D1001, 10.1093/nar/gkt1229
Burgess, 2011, Avoiding bias from weak instruments in Mendelian randomization studies, Int J Epidemiol., 40, 755, 10.1093/ije/dyr036
Burgess, 2016, Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods, Stat Med., 35, 1880, 10.1002/sim.6835
Burgess, 2014, Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome, Int J Epidemiol., 43, 922, 10.1093/ije/dyu005
Svingen, 2016, Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes, Clin Chem., 62, 755, 10.1373/clinchem.2015.250761
Davis, 2003, Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats, J Nutr., 133, 2907, 10.1093/jn/133.9.2907
Uthus, 2007, Dietary selenium affects homocysteine metabolism differently in Fisher-344 rats and CD-1 mice, J Nutr., 137, 1132, 10.1093/jn/137.5.1132
Allen, 2016, Selenium and prostate cancer: Analysis of individual participant data from fifteen prospective studies, J Natl Cancer Inst., 108, 10.1093/jnci/djw153
Brooks, 2001, Plasma selenium level before diagnosis and the risk of prostate cancer development, J Urol., 166, 2034, 10.1016/S0022-5347(05)65500-0
Li, 2004, A prospective study of plasma selenium levels and prostate cancer risk, J Natl Cancer Inst., 96, 696, 10.1093/jnci/djh125
Nomura, 2000, Serum selenium and subsequent risk of prostate cancer, Cancer Epidemiol Biomarkers Prev., 9, 883
van den Brandt, 2003, Toenail selenium levels and the subsequent risk of prostate cancer: A prospective cohort study, Cancer Epidemiol Biomarkers Prev., 12, 866
Yoshizawa, 1998, Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer, J Natl Cancer Inst., 90, 1219, 10.1093/jnci/90.16.1219
Ference, 2012, Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: A Mendelian randomization analysis, J Am Coll Cardiol., 60, 2631, 10.1016/j.jacc.2012.09.017
Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet., 366, 1267, 10.1016/S0140-6736(05)67394-1
Swerdlow, 2015, HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials, Lancet., 385, 351, 10.1016/S0140-6736(14)61183-1
Sattar, 2010, Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials, Lancet., 375, 735, 10.1016/S0140-6736(09)61965-6
Holmes, 2013, Secretory phospholipase A(2)-IIA and cardiovascular disease:, A Mendelian randomization study. J Am Coll Cardiol., 62, 1966, 10.1016/j.jacc.2013.06.044
Millwood, 2016, A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults, Int J Epidemiol., 45, 1588, 10.1093/ije/dyw087
Clinical Study Report for Study AN-CVD2233, 2012, Evaluation of the Safety and Efficacy of Short-Term A-002 Treatment in Subjects with Acute Coronary Syndromes.
Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: A Mendelian randomisation study, Lancet., 380, 572, 10.1016/S0140-6736(12)60312-2
Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N Engl J Med., 357, 2109, 10.1056/NEJMoa0706628
HPS2-THRIVE Collaborative Group, 2014, Effects of extended-release niacin with laropiprant in high-risk patients, N Engl J Med., 371, 203, 10.1056/NEJMoa1300955